✦ LIBER ✦

Weekly paclitaxel in patients with CAP-resistant advanced or recurrent endometrial carcinoma: a series of four patients

✍ Scribed by Shoko Akizuki; Noriyuki Katsumata; Yasuhiro Yamanaka; Masashi Andoh; Yasuhiro Fujiwara; Toru Watanabe

Publisher: Springer
Year: 2005
Tongue: English
Weight: 162 KB
Volume: 10
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-005-0482-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic study of weekly administ

Pharmacokinetic study of weekly administration dose of paclitaxel in patients with advanced or recurrent gastric cancer in Japan

✍ Michiya Kobayashi; Koji Oba; Junichi Sakamoto; Ken Kondo; Naoki Nagata; Takehiro 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 182 KB

A phase I study of a weekly schedule of

A phase I study of a weekly schedule of paclitaxel and carboplatin in patients with advanced carcinoma

✍ Wallace Akerley; Ritesh Rathore; Neil Ready; Louis Leone; William Sikov; Howard 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views

## Background: We conducted a phase i study of weekly paclitaxel (p) and carboplatin (c) in patients with advanced malignancies to determine the maximum tolerated dose (mtd) of this combination. ## Methods: Dose levels were escalated independently for patients with and without previous chemothera

Weekly cisplatin paclitaxel and continuo

Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study

✍ M. Schena; C. Barone; N. Birocco; D. Dongiovanni; G. Numico; I. Colantonio; O. B 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 207 KB

Randomized phase II study of weekly doce

Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma

✍ Lee M. Krug; Vincent A. Miller; Jyoti Patel; John Crapanzano; Christopher G. Azz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

Role of salvage chemotherapy with topote

Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel- and platinum-resistant recurrent ovarian or primary peritoneal cancer: A phase II pilot study

✍ Ghamande, Sharad A.; Piver, M. Steven 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

## Background and Objectives: We assessed the role of salvage chemotherapy with topotecan and cisplatin in patients with platinum-and paclitaxel-resistant advanced and recurrent ovarian or primary peritoneal cancer, based on the reported in vivo and in vitro synergism between these two drugs. Meth

Platinum-free combination chemotherapy i

Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma : A Phase I/II trial of gemcitabine, paclitaxel, and methotrexate

✍ Primo N. Lara Jr; Frederick J. Meyers; Lisa Y. Law; Nancy A. Dawson; Joan Housto 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## BACKGROUND Platinum‐based regimens have improved response rates and survival in patients with advanced transitional cell carcinoma (TCC) of the urothelial tract. However, the toxicities of platinum‐based chemotherapy are considerable. Regimens with reduced toxicity that are applicab